Emad Jafarzadeh
Overview
Explore the profile of Emad Jafarzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jafarzadeh E, Sarajar B, Lalani A, Rastegar-Pouyani N, Aliebrahimi S, Montazeri V, et al.
Curr Top Med Chem
. 2025 Feb;
PMID: 39950484
Introduction: The persistent drug resistance observed in lung cancer necessitates innovative strategies to improve therapeutic outcomes. This review investigates the potential of combining metformin (Met) and cisplatin (Cis) to overcome...
2.
Habibian Sezavar A, Rastegar-Pouyani N, Rahimi Kakavandi N, Fakhari F, Jafarzadeh E, Aliebrahimi S, et al.
Crit Rev Toxicol
. 2024 Dec;
54(10):981-995.
PMID: 39636584
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals used widely in industrial and commercial applications. Concerns exist about their potential link to cancer risk as possible endocrine-disrupting chemicals. We conducted...
3.
Zafari J, Sarajar B, Assar N, Moshaii A, Jafarzadeh E, Javani Jouni F
Photobiomodul Photomed Laser Surg
. 2024 Sep;
43(1):24-30.
PMID: 39324276
Colorectal adenocarcinoma is considered one of the major causes of cancer-related lethality among other type of malignancies. Given the several limitations and adverse outcomes of conventional therapeutic regimens against colorectal...
4.
Rastegar-Pouyani N, Farzin M, Karimi P, Jafarzadeh E, Haji Abdolvahab M, Najafi M
Curr Pharm Des
. 2024 Sep;
PMID: 39253924
Activin A (ActA) is a cytokine from the TGF-β superfamily that mediates a vast number of physiological mechanisms, mainly through the SMAD signaling pathway. Growing evidence indicates that ActA overexpression...
5.
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Jalali F, Fakhari F, Sepehr A, Zafari J, Sarajar B, Sarihi P, et al.
Transl Oncol
. 2024 Apr;
45:101946.
PMID: 38636389
Introduction: Doxorubicin (DOX) a chemotherapy drug often leads to the development of resistance, in cancer cells after prolonged treatment. Recent studies have suggested that using metformin plus doxorubicin could result...
6.
Zafari J, Rastegar-Pouyani N, Javani Jouni F, Najjar N, Azarshin S, Jafarzadeh E, et al.
Sci Rep
. 2024 Mar;
14(1):5792.
PMID: 38461218
Cisplatin is a chemotherapy drug widely used in cancer treatment. Alongside its clinical benefits, however, it may inflict intolerable toxicity and other adverse effects on healthy tissues. Due to the...
7.
Sharif M, Mohseni H, Khanavi M, Ghadami S, Jafarzadeh E, Tavajohi S, et al.
Anticancer Agents Med Chem
. 2023 Nov;
24(4):304-315.
PMID: 37957912
Background: Many cancer studies have intensely focused on the role of diet, among other factors involved in cancer establishment. The positive effect of green tea polyphenols (GTP) on controlling breast...
8.
Askari A, Poursadeghiyan M, Alinia A, Sephvand A, Jafarzadeh E, Nasl-Saraji G, et al.
Iran J Public Health
. 2023 Oct;
52(10):2157-2168.
PMID: 37899937
Background: Considering the necessity of health risk management, the present study conducted to provide a comprehensive model for identifying, evaluating, and prioritizing occupational health risks in an oilfield. Methods: We...
9.
Rastegar-Pouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E, et al.
Cancer Invest
. 2023 Jul;
41(7):656-671.
PMID: 37462514
This study comparatively evaluated the possible effects of recurrent and non-recurrent patient-derived Cancer-Associated Fibroblasts (CAFs-R and -NR) on the bladder cancer cell line, EJ138. Both groups of CAFs increased cisplatin...
10.
Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, et al.
Acta Histochem
. 2023 Jun;
125(6):152058.
PMID: 37336070
Glioblastoma multiforme (GBM) is one of the most aggressive brain and spinal cord tumors. Despite the significant development in application of antitumor drugs, no significant increases have been observed in...